No abstract
J Exp Clin Cancer Res. 2025 Dec 12. doi: 10.1186/s13046-025-03603-4. Online ahead of print.
NO ABSTRACT
PMID:41387887 | DOI:10.1186/s13046-025-03603-4
Targeting ATR offers multifaceted treatment strategies involving RAD51-mediated compensatory DNA repair in bladder cancer
Scritto il 12/12/2025
da Julia Pannhausen